GENET-news
To stay informed you can subscribe to the GENET-news list.
2007-02-05 | permalink
Chinese biotech hamstrung by production issues
s fast-developing biopharmaceutical industry is encountering a production bottleneck, challenging efforts to copy its success in other industries such as textiles and electronics. ”The production issue is quite important,” says Qihong Sun, a scientist at the Beijing-based Academy of Military Medical Sciences. ”If it is not properly handled, [China’s] progress in biotech research could be discounted.” Sun was referring specifically to delays in getting several biotech drugs made in China onto the market, long after their approval by regulators.
Overview
News
2007-02-05 | permalink
Chinese biotech hamstrung by production issues
s fast-developing biopharmaceutical industry is encountering a production bottleneck, challenging efforts to copy its success in other industries such as textiles and electronics. ”The production issue is quite important,” says Qihong Sun, a scientist at the Beijing-based Academy of Military Medical Sciences. ”If it is not properly handled, [China’s] progress in biotech research could be discounted.” Sun was referring specifically to delays in getting several biotech drugs made in China onto the market, long after their approval by regulators.
GENET-news & GENET-forum
GENET-news is providing a daily news service on a range of topics regarding genetic engineering. We are screening the worldwide English news, press releases and other publications to provide you with a strategic selection of information. GENET-news enables you to stay informed about all aspects of the global controversy around GE technologies and GE organisms. You can subscribe by 
email.
The GENET-forum list provides you with additional background information and more voluminous reports. It is only open for GENET members. Please contact the coordinator for membership and subscription.